Warning letter
Europharma Concepts Limited: warning letter of May 16, 2018
FDA warning letter 544738 · Center for Drug Evaluation and Research
Key facts
| Reference number | 544738 |
|---|---|
| Company | Europharma Concepts Limited |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | May 16, 2018 |
| Posted date | May 29, 2018 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 211.34, 211.84(d)(1), 211.100(a) |
| Inspection city | Clara |
| Inspection start date | Oct 31, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: